Atenolol description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Atenolol

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING


DOSAGE AND ADMINISTRATION

ATENOLOL DESCRIPTION


Atenolol




INACTIVE INGREDIENT



CLINICAL PHARMACOLOGY



PHARMACOKINETICS


DOSAGE AND ADMINISTRATION

PHARMACODYNAMICS














INDICATIONS & USAGE

Hypertension


Angina Pectoris Due to Coronary Atherosclerosis


Acute Myocardial Infarction
DOSAGE AND ADMINISTRATIONCONTRAINDICATIONSWARNINGS

ATENOLOL CONTRAINDICATIONS

WARNINGS


WARNINGS

Cardiac Failure



In Patients Without a History of Cardiac Failure
DOSAGE AND ADMNISTRATION



DOSAGE AND ADMINISTRATION

Concomitant Use of Calcium Channel Blockers
PRECAUTIONS

Bronchospastic Diseases


Anesthesia and Major Surgery

OVERDOSAGE

Diabetes and Hypoglycemia


Thyrotoxicosis
DOSAGE AND ADMINISTRATION

Untreated Pheochromocytoma


Pregnancy and Fetal Injury

PRECAUTIONS, Nursing Mothers



PRECAUTIONS

General


Impaired Renal Function
DOSAGE AND ADMINISTRATION

DRUG INTERACTIONS

Drug Interactions

WARNINGS








CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

Carcinogenesis, Mutagenesis, Impairment of Fertility



ANIMAL PHARMACOLOGY & OR TOXICOLOGY

Animal Toxicology


PREGNANCY


WARNINGS - Pregnancy and Fetal Injury

NURSING MOTHERS

Nursing Mothers

WARNINGS, Pregnancy and Fetal Injury

PEDIATRIC USE

Pediatric Use


GERIATRIC USE

Geriatric Use



CLINICAL PHARMACOLOGYINDICATIONS AND USAGE).
In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.




WARNINGS
Acute Myocardial Infarction








POTENTIAL ADVERSE EFFECTS






INDICATIONS AND USAGE


OVERDOSAGE












DOSAGE & ADMINISTRATION

rtension



Angina Pectoris



Acute Myocardial Infarction






Elderly Patients or Patients with Renal Impairment








Cessation of Therapy in Patients with Angina Pectoris


HOW SUPPLIED

Atenolol Tablets, USP























PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Atenolol

Atenolol

Atenolol

Atenolol TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-235(NDC:63304-622)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ATENOLOL ATENOLOL 50 mg

Inactive Ingredients

Ingredient Name Strength
MAGNESIUM CARBONATE
MAGNESIUM STEARATE
SILICON DIOXIDE
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STARCH, CORN

Product Characteristics

Color Size Imprint Code Shape
white 7 mm RE;20 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-235-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077877 2011-03-16


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.